Molecular Diagnostics enables the analysis of various disease states at the genomic and proteomic level; providing unparalleled testing accuracy and specificity. Infection Management is a major application for this technology, where microorganisms are individually identified by their genomic signatures. Infections often occur in a long term care facility and it is up to the managing clinicians and nurses to control them before they reach outbreak status.
To assist facilities in this regard, our infection management program in molecular diagnostics provides:
- Opportunities for better infection management with multiplexed detection of common pathogens from a single sample; for various applications, including respiratory infections, gastrointestinal pathogens, and wound infections*.
- Opportunities for cost savings by reducing unnecessary antibiotic use and prolonged quarantine procedures from ineffective therapy use.
- Opportunities for rapid management from initial identification of infection; a specific microorganism can be identified within 24 hours from shipment of sample (excluding courier shipment delays) for most applications.
Get Ahead of Outbreaks with Preemptive Infection Management Testing.
An Understanding of Genetics Can Help
Leading institutions have all spoken out about the benefits of genetic testing and how it can revolutionize drug therapies. By understanding a patient's unique genetic makeup, clinicians are empowered to make even more precise decisions regarding a patient's medication management.
Learn more about the link between genetics and medications:
AMA: What is Pharmacogenomics
US FDA: Understanding Precision Medicine
US FDA Blog: Launching of PrecisionFDA to Promote PMI
US FDA: Table of Pharmacogenomic Markers in Drug Labels
The Impact of Genetics is Real
The FDA has acknowledged a number of genetic markers, but the institutions that use them discover more every day. From the American Heart Association for drugs commonly used in cardiovascular disease management (Coumadin, Plavix, and Lipitor), to the American Psychiatric Association for various antidepressants and antipsychotics used in management of behavioral health (Xanax, Nortriptyline, and Adderall), and the American Academy of Pain Medicine for proper drug selection and dosing of potent opioids and other analgesics (Codeine, Ibuprofen, and Methadone), the impact of genetics is vast.